Sofia Kuzkina, MD (she/her/hers)

R-Pharm
Irvine, California, United States

6 years was working as Assistant of Professor, Ryazan Medical State University, then more that 10 years practice in medicine and 28 work in pharmaceutical business including 10 years in resarch and development.

Presentation(s):

• 0476: Impact of Comorbidity Burden on the Efficacy of, a Direct Interleukin 6 Inhibitor, Olokizumab: Real World Evidence

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): R-Pharm, JSC: Employee (Ongoing)

• 0503: Impact of Olokizumab on Pain in Rheumatoid Arthritis: a Meta-analysis

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): R-Pharm, JSC: Employee (Ongoing)

• 1323: Efficacy of Olokizumab in Treating Comorbid Depression in Patients with Rheumatoid Arthritis: Results of a Single-Center Randomized Controlled Trial

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): R-Pharm, JSC: Employee (Ongoing)